Imagin Medical
$0.02
0
+$0+0% Wednesday 16:30
Statistics
Day High
0.02
Day Low
0.02
52W High
0.28
52W Low
0.02
Volume
350
Avg. Volume
2,939
Mkt Cap
2.16M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
31DecConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-0.45
-0.33
-0.21
-0.09
Expected EPS
N/A
Actual EPS
-0.1105
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IMEXF. It's not an investment recommendation.
About
Other Metals/Minerals
Non-Energy Minerals
Health Services
Medical/Nursing Services
Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It offers the i/Blue Imaging System, which detects bladder cancer with advanced proprietary optics and light sensors; and enCage Coil, a disposable and focal therapy precision ablation device for use in the treatment of prostate cancer. The company is also developing technologies to visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. It has a license agreement with Lawrence Livermore National Security, LLC to develop and commercialize the i/Blue Imaging System. The company was founded in 1986 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Edward James Hutchens
Country
CA
ISIN
CA45250L2049
WKN
000A2QEY3